MSB 3.76% $1.03 mesoblast limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-78

  1. 3,749 Posts.
    lightbulb Created with Sketch. 357
    We all hope so! If we get another 'Complete Response Letter' SI will have a lot of explaining to do!

    The plan was Adult Trial and now all of a sudden that's out the window? The recent capital raise was to fund adult trial???

    Use of Proceeds
    Proceeds from the Placement and Entitlement Offer and existing cash reserves will be used to fund the
    adult Phase 3 registration trials for steroid-refractory acute-graft versus host disease and for chronic
    lower back pain, and general corporate purposes

    Someone changed goal posts again! Is it the FDA or is SI playing with us. This is what annoys investors! I must agree with Pledge's sentiments.

    I'll be nervous leading to the second half of 2024! This will be pivotal time for MSB.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.040(3.76%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.07 $1.07 $1.01 $13.19M 12.81M

Buyers (Bids)

No. Vol. Price($)
3 61090 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 239558 5
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.